Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in NTRA — Natera, Inc.

CIK 1423053 MIAMI, FL
Back to NTRA Full portfolio

Position in NTRA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$72,099,020
+$49,763,738 QoQ
Shares Held
265,607
+137.8% QoQ
Ownership
0.184%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#74
of 834 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NTRA Over Time

Shares Held

Position Value (USD)

Derivatives in NTRA

reported options exposure · as of Jun 30, 2026
CallValue
$30,918,155
CallShares
113,900
PutValue
$54,561,450
PutShares
201,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $1,783,709,630 across 35 Diagnostics & Research names. NTRA ranks #8 (4.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 574,992 $288,277,988
2 CRL
Charles River Laboratories International, Inc.
 1,193,601 $270,696,770
3 GH
Guardant Health, Inc.
 1,449,534 $217,473,585
4 DHR
Danaher Corp /De/
 943,694 $179,754,833
5 RVTY
Revvity, Inc.
 1,457,335 $162,143,091
6 A
Agilent Technologies, Inc.
 1,101,501 $146,312,377
7 TWST
Twist Bioscience Corp
 862,042 $88,686,880
8 NTRA
Natera, Inc.
This page 		265,607 $72,099,020

All Filings in NTRA

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $30,918,155 113,900
2026-06-30 $72,099,020 265,607
2026-06-30 $54,561,450 201,000
2026-03-31 $12,779,361 63,900
2026-03-31 $11,979,401 59,900
2026-03-31 $22,335,282 111,682
2025-12-31 $9,369,781 40,900
2025-12-31 $25,187,528 109,946
2025-12-31 $10,561,049 46,100
2025-09-30 $144,336,325 896,666
2025-09-30 $13,231,734 82,200
2025-09-30 $15,791,157 98,100
2025-06-30 $12,619,818 74,700
2025-06-30 $138,774,917 821,445
2025-06-30 $11,893,376 70,400
2025-03-31 $23,813,444 168,400
2025-03-31 $300,207,490 2,122,958
2025-03-31 $11,595,620 82,000
2024-12-31 $24,204,070 152,900
2024-12-31 $226,522,234 1,430,968
2024-12-31 $10,922,700 69,000
2024-09-30 $6,195,160 48,800
2024-09-30 $289,009,037 2,276,558
2024-09-30 $5,217,645 41,100
2024-06-30 $6,573,203 60,700
2024-06-30 $330,056,982 3,047,899
2024-06-30 $5,132,946 47,400
2024-03-31 $214,163,741 2,341,611
2024-03-31 $5,112,614 55,900
2024-03-31 $2,085,288 22,800
2023-12-31 $112,752 1,800
2023-12-31 $5,167,800 82,500
2023-12-31 $104,191,867 1,663,344
2023-09-30 $384,975 8,700
2023-09-30 $1,185,900 26,800
2023-09-30 $158,370 3,579
2023-06-30 $42,621,634 875,907
2023-06-30 $656,910 13,500
2023-06-30 $1,503,594 30,900
2023-03-31 $156,992,571 2,827,676
2023-03-31 $1,671,152 30,100
2023-03-31 $2,420,672 43,600
2022-12-31 $1,622,868 40,400
2022-12-31 $122,476,240 3,048,948
2022-12-31 $626,652 15,600
2022-09-30 $2,567,852 58,600
2022-09-30 $784,378 17,900
2022-09-30 $94,830,116 2,164,083
2022-06-30 $3,228,584 91,100
2022-06-30 $2,059,064 58,100

Report a Problem

Category
Description
Email (optional, for follow-up)